Methods and compositions for the treatment of pulmonary diseases

Details for Australian Patent Application No. 2005254101 (hide)

Owner Sepracor Inc.

Inventors Simon, John W.; Sullivan, Anne M.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005254101

PCT Pub. Number WO2005/123072

Priority 60/599,026 06.08.04 US; 60/578,828 14.06.04 US; 60/607,292 07.09.04 US

Filing date 14 June 2005

Wipo publication date 29 December 2005

International Classifications

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/54 (2006.01) - having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame

A61K 31/70 (2006.01) - Carbohydrates

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2005/123072 Priority application(s): WO2005/123072

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005254102-Five-membered heterocycles useful as serine protease inhibitors

2005254100-Automatic determination of the threshold of an evoked neural response